Discharge Medication Use Post-Operatively in GU Cancer Patients
Recruiting now
Conditions studied: Genitourinary Cancer
In brief
The main purpose of this research study is to determine the amount of opioids that are taken after discharge following a cystectomy, nephrectomy (partial or total), or prostatectomy surgeries via a 30-day post- discharge opioid use and disposal survey. We will also evaluate the impact of an opioid disposal education pamphlet on proper disposal of unused opioids.
Key facts
- Study ID
- NCT06795087
- Run by
- Wake Forest University Health Sciences
- People needed
- 684
- Starts
- 2025-02-21
- Expected to finish
- 2027-07-01
- Last updated by the study team
- 2026-07-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Written informed consent and HIPAA authorization for release of personal health information.
- Age ≥ 18 years at the time of enrollment
- Scheduled to undergo surgical cystectomy, partial or total nephrectomy or prostatectomy for a cancer diagnosis.
- Ability to read and understand the English and/or Spanish language.
- As determined by the enrolling investigator, ability of the participant to understand and comply with study procedures for the entire length of the study.
You may not qualify if…
- None
Where it is running
- Levine Cancer Institute — Charlotte, North Carolina, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.